DrugMonitor™ Anti-Seribantumab Antibody (VS-1224-YC1075)
CAT#: VS-1224-YC1075
Seribantumab is a fully human monoclonal antibody targeting Her3 with potential antineoplastic activity, used in trials for NSCLC, colorectal cancer, and other solid tumors. The DrugMonitor™ Anti-Seribantumab Antibody (VS-1224-YC1075) is an anti-drug antibody (ADA) against Seribantumab. This drug-based antibody is raised in mice immunized with the Seribantumab. The anti-Seribantumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Seribantumab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Seribantumab
- Target
- Seribantumab
- Immunogen
- Seribantumab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Seribantumab
- Related Disease
- NSCLC, colorectal cancer, and other solid tumors
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC1075. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "Seribantumab"
Anti-Human ERBB3/ErbB 3 Recombinant Antibody (Seribantumab)Recombinant humanized antibody expressed in CHO binding to human ERBB3. Seribantumab is used to treat cancer.
Afuco™ Anti-ERBB3 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-892)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human ERBB3.
Popular Products

Application: IF, IP, Neut, FuncS, ELISA, FC, WB

Application: IP, IF, FuncS, FC, Neut, ELISA, ICC

Application: IF, IP, Neut, FuncS, ELISA, FC, WB

Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-2.png)
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC

Application: Neut, ELISA, FuncS

Application: WB, IF, FuncS
-YJ-3.jpg)
Application: ELISA

Application: WB, ELISA, IF

Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR

Application: ELISA, FC, Inhib, FuncS

Application: Neut, FuncS, IHC, ELISA, FC, Inhib
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.











